-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Neutral on Gentex, Lowers Price Target to $24

Benzinga·04/14/2026 15:24:34
Listen to the news
UBS analyst Joseph Spak maintains Gentex (NASDAQ:GNTX) with a Neutral and lowers the price target from $25 to $24.